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Abstract
Background: The sequences of wild-isolate strains of Human Immunodeficiency Virus-1 (HIV-1) are characterized by low GC
content and suboptimal codon usage. Codon optimization of DNA vectors can enhance protein expression both by
enhancing translational efficiency, and by altering RNA stability and export. Although gag codon optimization is widely used
in DNA vectors and experimental vaccines, the actual effect of altered codon usage on gag translational efficiency has not
been quantified.
Methodology and Principal Findings: To quantify translational efficiency of gag mRNA in live T cells, we transfected Jurkat
cells with increasing doses of capped, polyadenylated synthetic mRNA corresponding to wildtype or codon-optimized gag
sequences, measured Gag production by quantitative ELISA and flow cytometry, and estimated the translational efficiency
of each transcript as pg of Gag antigen produced per mg of input mRNA. We found that codon optimization yielded a small
increase in gag translational efficiency (approximately 1.6 fold). In contrast when cells were transfected with DNA vectors
requiring nuclear transcription and processing of gag mRNA, codon optimization resulted in a very large enhancement of
Gag production.
Conclusions: We conclude that suboptimal codon usage by HIV-1 results in only a slight loss of gag translational efficiency
per se, with the vast majority of enhancement in protein expression from DNA vectors due to altered processing and export
of nuclear RNA.
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Introduction
HIV gene expression is controlled by multiple complex
regulatory mechanisms [1,2]. HIV structural proteins are
expressed from unspliced 9 kb (gag/pol) and partially-spliced 4 kb
(env) transcripts that are unstable and that cannot be efficiently
exported from the nucleus in the absence of the HIV regulatory
protein Rev. The lack of nuclear stability and export in the
absence of Rev is partly due to the presence of defined inhibitory
sequences (known as INS, IN, and CRS) within the structural
genes themselves. In addition, the low GC content of the HIV
RNA also contributes to nuclear instability, even in the absence of
defined inhibitory sequences [3]. Rev rescues 9 kb and 4 kb HIV
RNA from nuclear degradation by binding to the Rev Response
Element (RRE) located within the Env region of the genome,
stabilizing the RNA, and promoting RNA export [4].
For HIV-uninfected cells that are transfected with gag DNA, Gag
expression is greatly enhanced by codon optimization [5-11]. Codon
optimization originated as a means to enhance the translational
efficiency of genes with codon usage that was sub-optimal for the
transfected cell type. Increasing evidence suggests that the
enhancement of Gag expression by codon optimization in DNA-
transfected cells is largely attributable to changes in nuclear RNA
stability and export, rather than to enhanced translational efficiency
[10,12-14]. For example, in contrast to DNA transfection, when
non-optimized genes were expressed from cytoplasmic Sindbis
vectors [10] or synthetic mRNA [14], production of Gag and Env
proteins was readily detectable by Western blot and ELISA. These
results indicate that access to the cytoplasm is a major limiting factor
forexpressionofnon-codon-optimizedsequences.Howeverprevious
studies have not made precise comparisons of the translational
efficiency of codon-optimized versus non-optimized gag RNA, and it
is not known to what degree codon usage per se affects translational
efficiency of HIV transcripts.
To compare the translational efficiency of different transcripts in
the cytoplasm of transfected cells for the present study, we generated
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sequences, and transfected Jurkat cells by electroporation in the
presence of increasing amounts of synthetic mRNA. This method
introduces mRNA directly to the cytoplasm, thus bypassing the
requirement for mRNA transcription, processing and nuclear
export. We have previously shown that over 95% of cells subjected
to electroporation under similar conditions express the mRNA-
encoded product [15]. By measuring the amount of Gag produced
per pmol of mRNA, we estimated the translational efficiency of each
transcript. For comparison, we transfected Jurkat cells with DNA
vectors encoding the corresponding open reading frames for codon-
optimized or non-optimized gag under the control of the CMV-IE
promoter. Our results demonstrate that the vast majority of
enhancement of protein expression achieved by codon optimization
of DNA vectors is unrelated to codon usage per se, and actually
mediated by pre-translational effects, such as improved mRNA
stability and transport.
Results
To measure Gag production by transfected cells, we generated
synthetic mRNA encoding HIV-1 gag. Capped, polyadenylated
mRNA was transfected into Jurkat cells by electroporation. Gag
protein production was quantified by measuring the concentration
of Gag p24 in cell supernatant by ELISA and by staining
transfected cells with Gag-p24 specific fluorescent antibody. We
found that the amount of Gag released into the culture medium
was proportional to the amount of mRNA added to the
Figure 1. Gag expression in Jurkat cells transfected with gag mRNA. A. Gag production correlates with mRNA concentration. Jurkat cells
were transfected by electroporation with increasing doses of synthetic codon-optimized gag mRNA. After 24 hours, the amount of Gag in the
supernatant was determined by ELISA. The line shows linear fit (R
2.0.99). B. The amount of Gag in cell supernatants is representative of the median
Gag production in electroporated cells. Jurkat cells were transfected with varying doses of gag mRNA; after 24 hours, cell supernatants were
harvested for ELISA, and cell pellets were fixed, permeabilized, and stained with anti-Gag/p24 antibody. Gag production as measured by ELISA is
shown on the Y axis; Gag production as measured by MFI (median fluorescence intensity) is shown on the X axis. Line shows linear fit (R
2=0.93).
ELISA values are the average of triplicate wells.
doi:10.1371/journal.pone.0002356.g001
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2.0.99). The amount of Gag
detected by ELISA was proportional to the median fluorescence
intensity (MFI) of cells stained with p24-specific fluorescent
antibody (Figure 1B, R
2=0.93), demonstrating that the amount
of secreted Gag detected in cell supernatants was indicative of
protein production by the majority of cells in the population.
To compare the translational efficiency of different transcripts,
we used codon optimized or non-optimized gag sequences derived
from an HIV-1 Clade C clinical isolate[8]. To confirm that Gag
was poorly expressed from non-optimized transcripts transcribed
in the nucleus, we transfected Jurkat cells with DNA expression
vectors encoding optimized or nonoptimized gag sequences under
control of the CMV promoter. For optimized vector, we used the
previously described plasmid p96ZM651gag-opt[8]; for non-
optimized vector, we constructed plasmid p96ZM651gag-Non-
Opt2, encoding the matched non-optimized wildtype open
reading frame. Sequence analysis confirmed that the two vectors
were identical with respect to both the predicted peptide sequence
of the translational product and the 59 and 39 untranslated regions,
and differed only with respect to codon usage within the open
reading frame. As shown in Figure 2A, p24 was easily detectable in
the supernatant of cells transfected with codon-optimized DNA
vector, and was directly proportional to the concentration of
plasmid in the transfection. In contrast, no significant Gag
production was detected in cells transfected with the wild-type
sequence, consistent with the severe defect of protein expression
previously reported for non-optimzed sequence [8].
To measure the actual translational efficiency of optimized and
nonoptimized mRNA delivered directly to the cytoplasm, we
constructed transcriptional template vectors encoding identical
open reading frames as p96ZM651gag-opt or p96ZM651gag-
NonOpt2 above, and performed in vitro transcription to generate
capped, polyadenylated synthetic mRNA. Jurkat cells were
transfected with increasing amounts of mRNA, and the amount
of Gag in the supernatant after 24 hours was measured by ELISA.
The experiment was repeated for four separate batches of
synthetic mRNA, and the relative translational efficiency for each
transcript was estimated by calculating the slope of the curve (pg
p24/ mg mRNA). Figure 2B shows dose-dependent Gag
production for one representative of four independent experi-
ments. The translational efficiency of the optimized sequence was
only slightly enhanced compared to the non-optimized sequence
(1.7 pg vs 1.4 pg p24/ mg mRNA respectively). Among the four
independent experiments the ratio of the average translational
efficiency of optimized to non-optimized mRNA ranged from 1.2
to 1.9 (not shown), with an mean ratio of 1.6. Thus codon
optimization resulted in an approximately 60% increase in
translational efficiency.
To validate our comparison of translational efficiencies we
compared the effect of codon optimization to the effect of another
method of enhancing translational efficiency. For experiments
described above transfections were carried out using mRNA
capped with conventional m
7G(59)ppp(59)G cap analog. Transla-
Figure 2. Relative efficiency of Gag production from codon-
optimized and non-optimized sequences. A. Jurkat cells were
transfected with increasing amounts of plasmid DNA encoding codon-
optimized or non-optimized gag under control of the CMV-IE promoter,
and Gag production was measured by ELISA analysis of culture
supernatants. For codon-optimized sequence, Gag production was
directly proportional to the amount of input DNA. In contrast, for non-
optimized sequence no significant Gag production was detectable at
any dose of DNA. Representative of two independent experiments. B.I n
order to measure translational efficiency of mRNA introduced directly
into the cytoplasm, cells were transfected with increasing doses of
synthetic mRNA transcribed from codon-optimized or non-optimized
templates. The template sequences of the open reading frames were
identical to those used for the DNA transfections shown in A above. To
estimate the translational efficiency (amount of Gag produced per input
mg mRNA), we calculated the slope of the curve as shown.
Representative of four independent experiments. C. To determine the
effects of modified 59 cap on translational efficiency, cells were
transfected with increasing amounts of codon-optimized or non-
optimized mRNA generated with conventional m
7G(59)ppp(59)G cap
analog, or with anti-reverse cap analog (ARCA; which has been
previously reported to enhance translational efficiency of synthetic
mRNA). The Y axis shows the translational efficiency the mRNA
transcripts, derived from the slope of the curves as shown for B above.
doi:10.1371/journal.pone.0002356.g002
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an anti-reverse cap analog (ARCA) [16,17]. We compared the
translational efficiency of codon-optimized and non-optimized
mRNA synthesized with ARCA or conventional m
7G(59)ppp(59)G
cap analogs. Figure 2C shows that, consistent with results shown in
2B, when Gag production was measured 22 hours after transfec-
tion, the effect of codon optimization for all transcripts was an
enhancement of between 1.4 fold and 1.7 fold. Figure 2C also
shows that use of the ARCA cap enhanced translation by between
1.5 and 1.8 fold. This enhancement is comparable to the 2.3-2.6
fold enhancement in luciferase production reported for use of
ARCA in a reticulocyte lysate translation system [17]. Figure 2C
also shows that translational enhancement by codon optimization
and by use of ARCA cap is additive.
Discussion
Constructs bearing codon-optimized genes are widely used to
enhance heterologous expression of lentiviral gene products.
However, the term ‘‘codon optmization’’ is potentially confusing,
in that it implies that enhancement of expression is directly related
to codon usage and to translational efficiency. Here we report the
first quantitative assessment of the effect of codon optimization on
HIV-1 gag translational efficiency. Our results are consistent with
the conclusions of previous reports that for DNA-transfected cells,
the majority of enhancement in protein expression by gag codon
optimization is in fact due to increased stability and export of
nuclear mRNA. Nevertheless, we find a reproducible enhance-
ment (in four out of four experiments) of Gag production of
approximately 60% that can be attributed to codon optimization.
We propose that this value represents the actual difference in
translational efficiency due to suboptimal codon usage by clinical-
isolate HIV-1, although we also cannot rule out a possible
contribution of altered cytoplasmic mRNA stability based on
available data. Why a virus that has evolved to replicate in human
cells would maintain suboptimal codon usage is unexplained. It is
worth noting that the cellular editing enzyme APOBEC3G has a
cytidine deaminase activity that can induce G»A hypermutation in
the sequence of replicating HIV [18-20]; thus there may be
evolutionary pressure for HIV to use the minimal number of G-
containing codons as possible, even if it results in a slight reduction
of translational efficiency.
Finally we note that the combined effects of codon optimizaton
and ARCA cap (shown in Figures 2B and 2C) yielded a total
increase in protein production of approximately 2.3 fold compared
to wildtype transcript sequence with a conventional 59 cap. While
small compared to the effects of codon optimization for DNA
transfection, this enhancement may still be useful in light of




The non-optimized and optimized gag sequences were derived
from plasmids p96ZM651.8 (GenBank Accession #AF286224),
which contains the near full length molecular clone of an HIV-1
subtype C clinical isolate from Zambia; and p96ZM651gag-opt
(GenBank accession #AY181195), which contains a codon-
optimized gag sequence of p96ZM651 cloned into EcoRI and
BamHI cloning sites, 59R39 of vector pcDNA3.1(-). p96ZM651gag-
opt and p96ZM651.8 were provided by the AIDS Research and
Reference Reagent Program, Division of AIDS, NIAID, NIH (from
Drs. Yingying Li, Feng Gao, and Beatrice H. Hahn [8]). For DNA
transfection with optimized sequence Jurkats were transfected with
p96ZM651gag-opt. For DNA transfection with nonoptimized
sequence we constructed a new plasmid (p96ZM651gag-NonOpt2).
In order to construct p96ZM651gag-NonOpt2, we sequenced
p96ZM651gag-opt and determined that the 59 upstream sequence
including the vector EcoRI site and the start codon was
59GAATTCGGAAGACCCAGGAGAGAGATG, and the 39
downstream sequence including the stop codon and the vector
BamHI site was 59TAATGAGACGTGAGGATCC. Using these
sequences we designed specific PCR primers to clone the
nonoptimized gag from p96ZM651.8 into the EcoRI and BamHI
cloning sites of p96ZM651gag-opt, yielding a vector
(p96ZM651gag-NonOpt2) with identical 59 and 39 untranslated
regions to p96ZM651gag-opt.
Templates for in vitro transcription (IVT) of gag mRNA were
constructed by cloning the codon-optimized and non-optmized gag
sequence into template vectors consisting of: T7 polymerase
promoter, Kozak ribososme binding site, gag open reading frame,
64 nt poly-adenosine tail, AscI restriction site for linearization. All
plasmids were sequenced before use to confirm correct sequences.
Transfections
Synthetic mRNA was transcribed from the template plasmids
using Message Machine T7 or (T7 Ultra kit for ARCA-capped
mRNA) (Ambion). mRNA was purified with RNEasy kit (Qiagen)
and mRNA concentration was quantified with serial dilutions of
mRNA solutions using a ND-1000 spectrophotometer (Nano-
drop). For each transfection, 10
6 cells were washed twice with
OptiMem (Gibco) and resuspended in 300 ml of OptiMem with
the indicated concentration of mRNA or plasmid DNA, left on ice
for five minutes, and transfected by electroporation with a
GenePulserII (Biorad) at 900V/0.75mSec in a 4 mm cuvette.
Cells were then cultured in RPMI plus 10% fetal calf serum for
24 hours, after which conditioned medium was harvested for
analysis by p24 ELISA kit (PerkinElmer).
p24 determination
Transfected cells were cultured in RPMI plus 10% fetal calf
serum for 24 hours (RNA transfection) or 48 hours (DNA
transfection), after which conditioned medium was harvested for
analysis by p24 ELISA kit (PerkinElmer). Cell pellets were fixed
and permeablized using Fix/Perm kit (Becton Dickinson, San Jose,
CA), stained with anti-p24 antibody (KC-57-PE Beckman
Coulter), and analyzed on a BD FacsCalibur flow cytometer.
MFI was determined by gating on all live cells.
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